News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Colorado BioScience Association Releases Annual Bioscience Colorado Magazine At Biotechnology Industry Organization (BIO) International Convention In San Diego

6/25/2014 10:24:06 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DENVER--(BUSINESS WIRE)--The Colorado BioScience Association (CBSA) is releasing its annual edition of Bioscience Colorado, this week, at the BIO International Convention in San Diego, CA. The announcement is made by CBSA President & CEO April Giles, who says, “In this issue we are looking at the intersection of people and data, and how it benefits human health. Big Data is now playing a critical role within the bioscience industry—from the personal devices on our wrists monitoring our bodies, to electronic medical records housing our health histories—data is valuable.”

Bioscience Colorado is a key resource for companies, investors and economic developers, and has become the go-to source for the industry. With a total audience of over 8,000, including online impressions, this publication is one of the industry’s greatest voices—locally, nationally and internationally.

This new issue, Drawing People & Data Together to benefit human health, includes:

• Mobile Health in Colorado: Where “Big Data” Sparks Big Ideas
&bull Biodesix Harnesses Machine Learning and Analytics to Tackle Multivariate Diagnostics
&bullBioscience in Colorado Continues to Shine with U.S. Senator Michael Bennet
&bull Colorado Life Science Assets: A Sophisticated Repertoire of Clinical-Stage Therapeutic, Device and Diagnostic Products
&bull Boettcher Investigators: Webb-Waring Biomedical Research Program
&bullFound in Translation: Rocky Mountain Lions Eye Institute Translational Research Programs Focus on Innovative Treatment of Eye Diseases
&bullTech Transfer Offices Connect the Dots between Research and the Marketplace, Stimulate State’s Economy
&bullColorado by the Numbers: Financing and Acquisitions
&bull Grant Programs: Innovation Engines
&bull Colorado Bioscience Industry Directory

The complete flip book of the issue can be found online at:

Download pdf at:

Bioscience Colorado is an integral part of the Association’s mission to support the Colorado bioscience community through advocacy, resources and advancement of opportunities for collaboration. It reaches thousands of bioscience, economic development, legislative, university and industry leaders.

Colorado’s bioscience assets are also valuable. Device, diagnostic and therapeutic products created here have a significant economic impact—27,000 in total workforce— translating to over $10 billion in the State’s economy each year. In addition, over 60 acquisitions, financings and grants, totaling over $4 billion, were reported within the 2013 calendar year, further developing the industry’s ecosystem.

“Companies in Colorado have created important life-saving drugs and devices. We are proud to have continually grown the industry here and are excited for what the future brings. Bioscience in Colorado truly is driving innovation, creating jobs and improving lives,” Giles concludes.

About Colorado BioScience Association

CBSA is a not-for-profit organization providing services and support for Colorado's bioscience industry. With more than 350 members, CBSA actively works to promote the growth of the industry by advocating for a better business environment, growing the state's biotech workforce, fighting for policies that support a strong bioscience industry in the state, and speaking with a single voice on behalf of the industry. For more information, visit

CBSA also is found on these social media sites:

LinkedIn Group:
Facebook Fan Page:


Colorado BioScience Association
Mae Desaire, 720-382-5918
Director of Marketing
Absolutely Public Relations
Maggie Chamberlin Holben, APR, 303-984-9801

Help employers find you! Check out all the jobs and post your resume.

Read at

Related News

comments powered by Disqus